Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilot 2: Glucagon-like Peptide-1 in Sleep Disordered Breathing

Trial Profile

Pilot 2: Glucagon-like Peptide-1 in Sleep Disordered Breathing

Phase of Trial: Phase I/II

Latest Information Update: 19 Apr 2016

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 13 Apr 2016 Status changed from active, no longer recruiting to completed.
    • 03 Aug 2015 Planned number of patients changed from 20 to 30 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top